Quidelortho Corp $QDEL

Health Care

$14.21
+1.45 (+11.36%)
As of Oct 21, 2026, 6:19 AM EDT
Price history
Loading chart…

Quidelortho Corp (QDEL) is trading up at $14.21 (+11.36%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Quidelortho Corp revenue & net income history (FY2020–FY2025)

RevenueNet incomeNet margin (right axis, %)
$3.27B$607.0M−$2.05BFY2020 revenue: $1.66BFY2020 net income: $810.3M · Net margin 48.8%'20FY2021 revenue: $1.70BFY2021 net income: $704.2M · Net margin 41.5%'21FY2022 revenue: $3.27BFY2022 net income: $548.7M · Net margin 16.8%'22FY2023 revenue: $3.00BFY2023 net income: −$10.1M · Net margin −0.3%'23FY2024 revenue: $2.78BFY2024 net income: −$2.05B · Net margin −73.7%'24FY2025 revenue: $2.73BFY2025 net income: −$1.13B · Net margin −41.5%'25−50%0%50%100%FY2020 net margin: 48.8%FY2021 net margin: 41.5%FY2022 net margin: 16.8%FY2023 net margin: −0.3%FY2024 net margin: −73.7% (off the scale, which stops at −62.8%)FY2025 net margin: −41.5%
Quidelortho Corp annual financial statements
FY2020Jan 2021FY2021Jan 2022FY2022Jan 2023FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$1.66B$1.70B$3.27B$3.00B$2.78B$2.73B
Growth (year over year)—+2.2%+92.3%−8.2%−7.2%−1.9%
Gross profit$1.36B$1.28B$1.94B$1.50B$1.29B$1.27B
Gross margin81.6%75.3%59.3%49.9%46.2%46.7%
Operating income$1.06B$906.0M$843.7M$139.1M−$1.96B−$919.2M
Operating margin63.8%53.3%25.8%4.6%−70.5%−33.7%
Net income$810.3M$704.2M$548.7M−$10.1M−$2.05B−$1.13B
Net margin48.8%41.5%16.8%−0.3%−73.7%−41.5%
EPS (diluted)$18.60$16.43$9.56−$0.15−$30.54−$16.69
Balance sheet
Cash and equivalents$489.9M$802.8M$292.9M$118.9M$98.3M$169.8M
Total assets—$2.43B$8.86B$8.56B$6.42B$5.77B
Total liabilities—$501.0M$3.92B$3.56B$3.44B$3.85B
Long-term debt—$700.0K$2.43B$2.27B$2.14B$2.47B
Shareholders' equity$1.33B$1.93B$4.93B$5.01B$2.98B$1.92B
Cash flow
Operating cash flow$629.7M$805.9M$885.3M$280.2M$83.0M$105.2M
Capital expenditure$64.9M$292.8M$140.9M$209.3M$195.1M$188.2M
Free cash flow$564.8M$513.1M$744.4M$70.9M−$112.1M−$83.0M
Share buybacks$43.7M$103.5M$74.3M$7.20M$0$0

From Quidelortho Corp's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Quidelortho Corp

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.

Source: Wikipedia — QuidelOrtho

Headquarters
San Diego, California From SEC filings, Oct 2026

Recent News (4)

More Health Care stocks

Browse all companies →